Health Daré Bioscience Announces Positive Efficacy Results from the DARE-HRT1 Phase 1 / 2 Study James Pereira Oct 17, 2022 Statistically Significant Results for Improvement in both the Vasomotor and the Vaginal Symptoms of Menopause… Read More...
Health Daré Bioscience Announces IDE Approval for a Single Arm, Open-Label Pivotal Contraceptive Efficacy… James Pereira Oct 10, 2022 SAN DIEGO, Oct. 10, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health… Read More...
Entertainment Chhavi Mittal talks about tackling painful side effects of radiotherapy after surgery: ‘Jab… Eli Pacheco Jun 15, 2022 Actor Chhavi Mittal has spoken about the side effects of radiation, she is going through, post her breast cancer… Read More...
Health Daré Bioscience to Participate in Upcoming Conference James Pereira Apr 17, 2022 SAN DIEGO, April 14, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health… Read More...
Health Daré Announces FDA Approval of XACIATO™ (clindamycin phosphate) Vaginal Gel as a Treatment for… James Pereira Dec 8, 2021 Prescribing information supports positioning of XACIATO as a first line option for the treatment of bacterial… Read More...